Investing News NetworkYour trusted source for investing success

Videos
Companies
Press Releases
Top Stocks
Top Resource Stocks
Top Tech Stocks
Top Life Science Stocks
Private Placements
Trending
Trending Articles

How Would a New BRICS Currency Affect the US Dollar? (Updated 2024)

Could the Silver Price Really Hit $100 per Ounce? (Updated 2024)

7 Biggest Lithium-mining Companies in 2024

Top 10 Oil-producing Countries (Updated 2024)

How to Invest in OpenAI's ChatGPT (Updated 2024)

Uranium Stocks: 5 Biggest Companies in 2024

Where Does Tesla Get its Lithium? (Updated 2024)

Hydrogen Stocks: 9 Biggest Companies in 2024

Top 10 Countries for Natural Gas Production (Updated 2024)

Trending Press Releases

SIRONA BIOCHEM Poised for Profitability in 2025 with Anti-Aging Product Rollout

Altech – CERENERGY® First 60 KWh Prototype Online and Achieving Great Results

In Search of Alternative Financing for Critical Minerals Projects

Glencore Loan Facility Closed, Offtakes Executed

Vertex Acquires Drill Rig to Advance Exploration, at the High-Grade Reward Gold Mine, Below the Existing Resource

More Press Releases
Trending Companies

Saga Metals

SAGA:CA

Sociedad Quimica y Minera S.A. (SQM)

SQM:NYE

Albemarle Corporation

ALB

Altech Batteries

ATC:AU
More Companies
Trending Reports

2024 Lithium Market Outlook

Silver Price Forecast - What Happened And Where Do We Go From Here?

2024 Energy Outlook Report

Rare Earths Outlook Report

More Outlook Reports
Resource
Resource
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Tech
Tech
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Life Science
Life Science
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Gold Price
Silver Price
Copper Price
Oil Price
Uranium
Artificial Intelligence
loader

BioAtla Inc.

NASDAQ:BCAB
Press Releases

BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of highly specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise Mecbotamab vedotin, Ozuriftabmab vedotin, BA3071, and Bispecific antibody programs.

Interactive Chart

×